Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Aclarion Inc (ACON) is an innovative healthcare technology company focused on transforming the diagnosis and management of musculoskeletal conditions through advanced non-invasive imaging and data analytics. Leveraging machine learning capabilities, Aclarion provides healthcare professionals with actionable insights that improve clinical outcomes while optimizing cost-effective treatment pathways. As a key player in the digital health arena, the company is positioned to address the growing demand for effective diagnostic solutions, thereby enhancing patient care and management in a rapidly evolving healthcare environment. Aclarion's commitment to improving patient outcomes places it at the forefront of future healthcare delivery advancements.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$2.95
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 6, 2026 | $-1.05 | $-1.12 | Miss -6.7% | $-1.12 | — | $25.21K | — | 1D Pre-0.8% | On-Day-0.4% | 1D Post-2.6% |
Q ended Mar 31, 2026 Reported May 21, 2026 | $-1.55 | $-1.34 | Beat +13.5% | — | — | $21.14K | — | 1D Pre-0.3% | On-Day+2.2% | 1D Post-1.5% |
Q ended Dec 31, 2025 Reported Feb 25, 2026 | $-3.60 | |||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| $-4.51 |
| Miss -25.3% |
| — |
| — |
| $18.48K |
| — |
| 1D Pre+1.2% |
| On-Day+6.3% |
| 1D Post0.0% |
Q ended Sep 30, 2025 Reported Nov 12, 2025 | $-2.64 | $-2.93 | Miss -11.0% | — | — | $18.94K | — | 1D Pre-1.4% | On-Day-3.4% | 1D Post-10.8% |